Hepatocellular<unk>  is more common in women in Western countries where they are exposed to higher doses of oral contraceptives. The estimated incidence is 3 per 100,000 individuals/year and is 3 to 4 per 100,000 individuals with long term history of oral contraceptive use. It is more common in women of childbearing age who take oral contraceptives and can rarely occur in men who take long term anabolic androgenic steroids.
Hepatocellular adenoma epidemiology and demographics
Hepatocellular carcinoma epidemiology and demographics
Hepatocellular adenoma pathophysiology
Hepatic hemangioma epidemiology and demographics
Primary biliary cirrhosis epidemiology and demographics
Fatty liver epidemiology and demographics
Non-alcoholic fatty liver disease epidemiology and demographics
Fibroadenoma epidemiology and demographics